The Fight Against Diabetes
Diabetes has emerged as one of the most pressing health challenges of our time. Once considered a manageable chronic illness, it has grown into a global public health crisis, affecting millions of people across all ages, health systems, and economies. Rising prevalence among children, adults, pregnant women, and older adults underscores the disease’s pervasive impact. Beyond hospital wards, diabetes now affects workplaces, schools, households, and national economies, creating an urgent need for effective prevention, early detection, and ongoing care strategies that reach every segment of society.
Globally, an estimated 589 million adults currently live with diabetes, and this number continues to grow at an alarming rate. The burden of the disease is not limited to healthcare costs alone; it extends to lost productivity, absenteeism, and premature mortality, affecting societies far beyond clinic walls. Without timely intervention, the global impact is projected to worsen in the coming years, placing further pressure on long-term development goals, national budgets, and community health systems.
Diabetes is no longer a health challenge that can be solved by medications alone. It demands collaboration across governments, research institutions, clinics, and communities.
The Middle East faces a particularly high risk due to rapid urbanization, changing lifestyles, and genetic predispositions that increase susceptibility to diabetes. Research suggests that by 2050, the region could incur annual economic losses of up to $1.5 trillion if current trends persist unchecked. In 2023 alone, the Middle East spent $639 billion on diabetes-related costs, with nearly 90 percent attributed to indirect losses, including decreased productivity, absenteeism, and premature deaths. These figures highlight that diabetes is no longer solely a clinical concern but a significant economic, social, and societal risk that threatens the development and sustainability of communities throughout the region.
The changing face of diabetes
One of the most concerning trends in recent years is the increasing diagnosis of type 2 diabetes in younger adults. While the disease was historically associated with individuals over 40, clinicians now meet patients in their 20s and 30s exhibiting early signs of diabetes and its complications. Early onset diabetes is linked with faster progression of cardiovascular disease, kidney disorders, and stroke, often resulting in a shorter life expectancy compared to those diagnosed later in life. The earlier onset also places a heavier burden on healthcare systems, as younger patients often require long-term management spanning decades rather than years.
Delayed diagnosis remains a key challenge. Many adults remain unaware of their condition and may not seek treatment until complications arise, sometimes presenting only when vision problems, severe fatigue, or cardiovascular issues develop. Fragmented care systems and low public awareness contribute to these delays, while lifestyle factors such as long working hours, sedentary habits, and widespread availability of ultra-processed foods accelerate the early development of metabolic disorders. Addressing both behavioural and systemic factors is essential to prevent the disease before it progresses to serious complications. This shift in the epidemiology of diabetes underscores the importance of early detection and preventive measures at both individual and population levels, ensuring that care begins well before complications take hold.
Innovation in care
Advances in diagnostics and treatment are beginning to reshape the management of diabetes. Traditional tools such as HbA1c tests remain central to diagnosis and monitoring, but newer approaches, including early detection programs for type 1 diabetes, have the potential to identify individuals at risk before symptoms even appear. While these programs are not yet universally implemented, they demonstrate a proactive approach that could transform care by enabling preventive interventions at an earlier stage, ultimately reducing long-term complications and improving outcomes for patients.
Treatment options have evolved rapidly over the past decade. New therapies now support weight management, cardiovascular health, kidney protection, and more personalized approaches tailored to individual risk factors and lifestyle circumstances. Digital technologies such as continuous glucose monitoring systems, insulin pumps, and emerging artificial intelligence applications allow for more precise, adaptive, and patient-centered care. These tools give individuals better control over their condition, reduce stress associated with day-to-day management, and improve quality of life. Younger patients, in particular, benefit from these innovations, as they can integrate care seamlessly into their daily routines, supporting long-term adherence and healthier outcomes.
Diabetes is no longer a health challenge that can be solved by medications alone. It demands collaboration across governments, research institutions, clinics, and communities.
Artificial intelligence and predictive analytics are also showing promise, helping clinicians optimize treatment plans, determine insulin dosing more accurately, and anticipate potential complications before they arise. These advancements signal a future in which diabetes care can become increasingly preventive, adaptive, and tailored to individual behaviour and physiology rather than relying solely on generalized treatment protocols. The integration of technology and precision medicine is gradually redefining what it means to manage diabetes effectively in the modern era.
Diabetes in pregnancy
Diabetes during pregnancy is becoming increasingly common, affecting approximately one in six pregnancies worldwide. Rising maternal age, obesity, and sedentary lifestyles have contributed to this trend, and the condition poses significant risks to both mother and child if not managed proactively. Global guidelines emphasize early screening, personalized care, and home-based monitoring as critical strategies for protecting maternal and fetal health. Multidisciplinary management involving obstetricians, endocrinologists, nutritionists, and nurses is essential to ensure comprehensive care from conception through the postpartum period.
Despite improvements in care, many women with type 2 diabetes discover their pregnancy late or receive limited support early on, which can lead to complications such as pre-eclampsia, preterm birth, and increased risk of neonatal metabolic issues. Early intervention, including individualized nutrition plans, tailored physical activity, and regular glucose monitoring, can prevent many of these adverse outcomes. The focus on preventive measures and coordinated care highlights the need to address diabetes not just as a maternal health issue but as a condition with implications for two lives simultaneously.
UAE’s diabetes strategy
Countries across the Middle East, particularly the UAE, are actively implementing programs to improve early detection, prevention, and education. National screening initiatives aim to identify individuals at risk before complications develop, while education programs provide patients with practical guidance on monitoring glucose levels, adjusting dietary habits, and adopting healthier lifestyles. Schools are increasingly targeted for awareness programs, introducing children to physical activity, balanced nutrition, and knowledge about family history. By instilling these habits early, health systems aim to reduce the incidence of diabetes and related metabolic disorders in adulthood.
Education and prevention initiatives are complemented by strategies to empower patients. Programs are designed to equip individuals with the knowledge and skills necessary to manage their condition independently, reducing reliance on hospital-based care while encouraging long-term adherence to lifestyle and treatment plans. By emphasizing prevention, early detection, and patient education, the UAE aims to mitigate the burden of diabetes, reduce complications, and improve outcomes across all age groups.
Identifying the gaps
Despite significant progress, challenges remain across the region and globally. A large proportion of individuals with diabetes remain undiagnosed, with estimates suggesting that nearly 40 percent of adults are unaware of their condition. Access to essential treatment is uneven, and some countries still face shortages of insulin, oral medications, or digital monitoring tools. Comprehensive long-term management requires coordinated care across multiple specialties, yet fragmented systems often leave patients without full support for nutrition, cardiovascular health, or renal monitoring.
Public awareness campaigns frequently fail to reach younger populations, and social media, which could be a powerful communication tool, stays underutilized. Long-term outcomes for women, particularly during menopause and the postpartum period, remain under-researched, highlighting critical gaps in scientific understanding and clinical practice. These gaps underscore the need for more inclusive research, improved public engagement, and health system reform to ensure that diabetes care is effective, accessible, and equitable across different demographics.
Managing diabetes continuously
The theme of World Diabetes Day 2025, “Diabetes Across Life Stages,” calls for a life-course approach that acknowledges the long-term nature of risk factors, which begin in early life and continue into old age. Genetics, environment, and lifestyle all play crucial roles in shaping risk, making prevention, early detection, and ongoing care essential at every stage. Policymakers are encouraged to invest in healthier food systems, urban designs that promote physical activity, and school-based nutrition programs. Strengthening primary healthcare systems through training, screening, and community-level support is critical, while technology can simplify monitoring, reduce stress, and enhance treatment accuracy.
Artificial intelligence is also emerging as a promising tool. Recent studies have shown how AI models can support insulin dosing and help personalize treatment.
Empowering patients is equally vital. Diabetes management is not a single intervention but a lifelong commitment requiring daily decisions, emotional resilience, and sustained support. Families, schools, and communities play a crucial role in creating environments conducive to healthy behaviours and long-term adherence. Raising awareness, promoting behavioural change, and ensuring access to resources can significantly reduce the burden of diabetes on both individuals and society as a whole.
The impact of diabetes extends beyond the individual to affect schools, workplaces, households, and national economies. Addressing the challenge requires collaboration among governments, healthcare providers, research institutions, and communities. Integrated strategies that combine prevention, personalized care, and patient empowerment are essential to reduce the burden and improve quality of life. Ongoing key initiatives in UAE demonstrate that progress is achievable, with early detection programs, structured education, and digital innovations paving the way for better outcomes.
The journey toward reducing the global impact of diabetes is long and complex, but every intervention matters. Each step taken to promote awareness, encourage prevention, and improve care contributes to a healthier future. With sustained commitment, smarter prevention strategies, and better access to care, societies can mitigate the effects of diabetes and create conditions in which individuals can live healthier, more productive lives.
Diabetes can no longer be addressed through medication alone. Its pervasive impact requires a comprehensive approach that integrates prevention, treatment, education, and technological innovation. By adopting a life-course perspective, health systems can identify risks early, intervene effectively, and support individuals throughout their lives. The path ahead is challenging, but the progress made in awareness, screening, and innovation offers a roadmap for meaningful change.
Across the Middle East and the rest of the world, initiatives underway today show that tackling diabetes is achievable. Every measure taken today helps ensure a future where diabetes no longer dictates health outcomes or economic stability. The effort requires collaboration, sustained action, and commitment at every level, from government to clinic to household, but the potential benefits are profound.
With the global and regional diabetes burden on the rise, the focus must remain on integrating prevention, personalized treatment, and patient empowerment into everyday healthcare practice. Only through coordinated, multi-level action can societies reduce the burden of diabetes and improve the quality of life for millions living with the disease. The road ahead may be long, but the steps taken today lay the foundation for a healthier, more resilient tomorrow.
